Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I welcome this debate today as we discuss an idea with merit to apply the savings of bulk negotiation to the prescription drugs taxpayers purchase through the Medicare…
Mr. Speaker, I yield myself such time as I may consume.
Mr. Speaker, I welcome this debate today as we discuss an idea with merit to apply the savings of bulk negotiation to the prescription drugs taxpayers purchase through the Medicare program.
This debate rests on a single question: Where would we be if the taxpayer dollar was used to buy ammunition for our soldiers one bullet at a time? What would happen if the Department of Transportation purchased concrete mix one bag at a time? Would we instruct the IRS to purchase paper one sheet at a time? Why then do we bar the Secretary of Health and Human Services from acting on the taxpayers' behalf and, instead, expect Medicare to buy drugs one plan at a time, one pill at a time?
This bill corrects that inequity, and I look forward to our debates today.
Mr. Speaker, I reserve the balance of my time.
Mr. Speaker, at this time I yield 2 minutes to the distinguished colleague of ours from Farmville, North Carolina (Mr. Jones).
Mr. Speaker, I yield myself such time as I may consume.
I simply want to respond to an issue that was raised by our colleague from Georgia with regard to the impact on community pharmacists. I would submit for the Record this letter, statement by the Association of Community Pharmacists in support of H.R. 4 saying H.R. 4 does no harm to community pharmacists. We cannot find any provision in H.R. 4 that would either improve or diminish the situation that they are currently faced with regard to the pharmacy benefit managers who are negotiating with them as well as well as taking profit from the pharmacies. This is what is happening because of Medicare part D today.
The Association of Community Pharmacists Statement on H.R. 4 and Response to Assertions That H.R. 4 Is Harmful to Community Pharmacists
H.R. 4 does no harm to community pharmacists. The real harm
done to community pharmacists occurred when Congress passed,
and the President signed into law, the original Medicare
Modernization Act (MMA) in 2003. Direct negotiation as
contained in H.R. 4 will not directly impact pharmacies
because pharmacies are currently being reimbursed at a loss
regardless. If this legislation succeeds in bring drug prices
down, it will only reduce the top line sales figure--but will
have no effect on the gross margin of pharmacies or the
ability of pharmacies to continue to operate.
The MMA allowed for Pharmacy Benefit Managers (PBMs) to
mandate ridiculously low dispending fees with no minimum to
protect pharmacies. ACP cannot find any provision in H.R. 4
that would either improve or diminish this situation.
The real problem in Medicare Part D is that PBM profits
have increased at the expense and detriment of beneficiaries
and community pharmacies. Beneficiaries and community
pharmacies will not have any true relief until Congress stops
the PBMs from taking a vast and disproportionate share of the
money out of the system.
Mr. Speaker, at this time I yield 1 minute to my friend and neighbor from Kansas (Mr. Moore).
Mr. Speaker, at this time I am privileged to yield 3 minutes to the gentleman from Indiana (Mr. Burton).
Mr. Speaker, I yield myself 15 seconds to respond.
Number one, I would like to submit for the Record the list of the 12 different anti-cholesterol drugs on the VA formulary that exist today.
And second, I would quote from the Institute of Medicine Committee, part of the National Academy of Sciences. They concluded that the ``VA national formulary is not overly restrictive. In some respects it is more; but in many respects, it is less restrictive than other public or private formularies.'' I also will submit that for the Record.
Mr. Speaker, I yield myself 15 seconds.
I would simply say that it is important for my colleagues to know that the same pharmacy benefit managers whom we have entrusted to negotiate the price of our own seniors' drugs are now being investigated in over 25 States for questionable business practices.
Mr. Speaker, I reserve the balance of my time.
Mr. Speaker, 80 million baby boomers are getting ready to retire, and yesterday the General Accountability Office's comptroller David Walker said, ``If there is one thing that is going to bankrupt America, it is health care.'' Adding that the Medicare
prescription drug benefit alone has added $8 trillion, $8 trillion in government obligations, more than all of Social Security over the past 6 years.
I would like to remind my friends that this is government obligation because Medicare is a government-run program. It is not a private- sector program.
But H.R. 4, Mr. Speaker, won't create price controls, it will not limit choice, and it will not force pharmacies out of business, which is why the National Community Pharmacists Association endorses H.R. 4. It could add more competition, more opportunity to lower drug costs for our seniors, keeping them out of the doughnut hole just a little while longer.
Let us not solely entrust the negotiations of drug prices, Mr. Speaker, to the very companies who profit from the sales of these drugs. The American public has entrusted us with their hardearned tax dollars. Let us show them that we honor that trust and use every tool possible to lower the costs of the Medicare prescription drug program.
Each of us was elected, Mr. Speaker, to represent our constituents, not big PhRMA, not the pharmacy benefit managers who prey on our community pharmacists. Support H.R. 4 and bring more competition to this position.